IgG Fc sialylation is regulated during the germinal center reaction following immunization with different adjuvants.


Journal

The Journal of allergy and clinical immunology
ISSN: 1097-6825
Titre abrégé: J Allergy Clin Immunol
Pays: United States
ID NLM: 1275002

Informations de publication

Date de publication:
09 2020
Historique:
received: 12 12 2019
revised: 23 04 2020
accepted: 24 04 2020
pubmed: 24 5 2020
medline: 11 3 2021
entrez: 24 5 2020
Statut: ppublish

Résumé

Effector functions of IgG Abs are regulated by their Fc N-glycosylation pattern. IgG Fc glycans that lack galactose and terminal sialic acid residues correlate with the severity of inflammatory (auto)immune disorders and have also been linked to protection against viral infection and discussed in the context of vaccine-induced protection. In contrast, sialylated IgG Abs have shown immunosuppressive effects. We sought to investigate IgG glycosylation programming during the germinal center (GC) reaction following immunization of mice with a foreign protein antigen and different adjuvants. Mice were analyzed for GC T-cell, B-cell, and plasma cell responses, as well as for antigen-specific serum IgG subclass titers and Fc glycosylation patterns. Different adjuvants induce distinct IgG This study's findings regarding adjuvant-dependent GC responses and IgG glycosylation programming may aid in the development of novel vaccination strategies to induce IgG Abs with both high affinity and defined Fc glycosylation patterns in the GC.

Sections du résumé

BACKGROUND
Effector functions of IgG Abs are regulated by their Fc N-glycosylation pattern. IgG Fc glycans that lack galactose and terminal sialic acid residues correlate with the severity of inflammatory (auto)immune disorders and have also been linked to protection against viral infection and discussed in the context of vaccine-induced protection. In contrast, sialylated IgG Abs have shown immunosuppressive effects.
OBJECTIVE
We sought to investigate IgG glycosylation programming during the germinal center (GC) reaction following immunization of mice with a foreign protein antigen and different adjuvants.
METHODS
Mice were analyzed for GC T-cell, B-cell, and plasma cell responses, as well as for antigen-specific serum IgG subclass titers and Fc glycosylation patterns.
RESULTS
Different adjuvants induce distinct IgG
CONCLUSION
This study's findings regarding adjuvant-dependent GC responses and IgG glycosylation programming may aid in the development of novel vaccination strategies to induce IgG Abs with both high affinity and defined Fc glycosylation patterns in the GC.

Identifiants

pubmed: 32445838
pii: S0091-6749(20)30728-4
doi: 10.1016/j.jaci.2020.04.059
pii:
doi:

Substances chimiques

Addavax 0
Adjuvants, Immunologic 0
Alum Compounds 0
Antigens 0
Cytokines 0
Immunoglobulin G 0
Lipopolysaccharides 0
Monatide (IMS 3015) 0
Polysorbates 0
aluminum sulfate 34S289N54E
Squalene 7QWM220FJH
Mineral Oil 8020-83-5
Ovalbumin 9006-59-1
Freund's Adjuvant 9007-81-2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

652-666.e11

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Yannic C Bartsch (YC)

Laboratories of Immunology and Antibody Glycan Analysis, Institute for Nutritional Medicine, University of Lübeck and University Medical Center Schleswig-Holstein, Lübeck, Germany.

Simon Eschweiler (S)

Laboratories of Immunology and Antibody Glycan Analysis, Institute for Nutritional Medicine, University of Lübeck and University Medical Center Schleswig-Holstein, Lübeck, Germany.

Alexei Leliavski (A)

Laboratories of Immunology and Antibody Glycan Analysis, Institute for Nutritional Medicine, University of Lübeck and University Medical Center Schleswig-Holstein, Lübeck, Germany.

Hanna B Lunding (HB)

Laboratories of Immunology and Antibody Glycan Analysis, Institute for Nutritional Medicine, University of Lübeck and University Medical Center Schleswig-Holstein, Lübeck, Germany.

Sander Wagt (S)

Laboratories of Immunology and Antibody Glycan Analysis, Institute for Nutritional Medicine, University of Lübeck and University Medical Center Schleswig-Holstein, Lübeck, Germany; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.

Janina Petry (J)

Laboratories of Immunology and Antibody Glycan Analysis, Institute for Nutritional Medicine, University of Lübeck and University Medical Center Schleswig-Holstein, Lübeck, Germany.

Gina-Maria Lilienthal (GM)

Laboratories of Immunology and Antibody Glycan Analysis, Institute for Nutritional Medicine, University of Lübeck and University Medical Center Schleswig-Holstein, Lübeck, Germany.

Johann Rahmöller (J)

Laboratories of Immunology and Antibody Glycan Analysis, Institute for Nutritional Medicine, University of Lübeck and University Medical Center Schleswig-Holstein, Lübeck, Germany; Department of Anesthesiology and Intensive Care, University Medical Center Schleswig-Holstein, Lübeck, Germany.

Noortje de Haan (N)

Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.

Alexandra Hölscher (A)

Infection Immunology, Research Center Borstel, Borstel, Germany.

Raghu Erapaneedi (R)

Institute for Pathology, University of Würzburg, Würzburg, Germany.

Anastasios D Giannou (AD)

First Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Lilian Aly (L)

Department of Neurology, Technical University of Munich, Klinikum rechts der Isar, Germany.

Ryota Sato (R)

Laboratory for Lymphocyte Differentiation, RIKEN Center for Integrative Medical Sciences, Yokohama, Kanagawa, Japan.

Louise A de Neef (LA)

Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.

André Winkler (A)

Laboratories of Immunology and Antibody Glycan Analysis, Institute for Nutritional Medicine, University of Lübeck and University Medical Center Schleswig-Holstein, Lübeck, Germany; Laboratory of Tolerance and Autoimmunity at the German Rheumatism Research Center, a Leibniz Institute, Berlin, Germany.

Dominique Braumann (D)

Laboratories of Immunology and Antibody Glycan Analysis, Institute for Nutritional Medicine, University of Lübeck and University Medical Center Schleswig-Holstein, Lübeck, Germany; Institute of Laboratory Medicine, Clinical Chemistry and Pathobiochemistry, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Juliane Hobusch (J)

Laboratories of Immunology and Antibody Glycan Analysis, Institute for Nutritional Medicine, University of Lübeck and University Medical Center Schleswig-Holstein, Lübeck, Germany.

Kyra Kuhnigk (K)

Laboratories of Immunology and Antibody Glycan Analysis, Institute for Nutritional Medicine, University of Lübeck and University Medical Center Schleswig-Holstein, Lübeck, Germany.

Vanessa Krémer (V)

Laboratories of Immunology and Antibody Glycan Analysis, Institute for Nutritional Medicine, University of Lübeck and University Medical Center Schleswig-Holstein, Lübeck, Germany.

Moritz Steinhaus (M)

Laboratories of Immunology and Antibody Glycan Analysis, Institute for Nutritional Medicine, University of Lübeck and University Medical Center Schleswig-Holstein, Lübeck, Germany.

Véronique Blanchard (V)

Institute of Laboratory Medicine, Clinical Chemistry and Pathobiochemistry, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Timo Gemoll (T)

Section for Translational Surgical Oncology & Biobanking, Department of Surgery, University of Lübeck and University Medical Center Schleswig-Holstein, Lübeck, Germany.

Jens K Habermann (JK)

Section for Translational Surgical Oncology & Biobanking, Department of Surgery, University of Lübeck and University Medical Center Schleswig-Holstein, Lübeck, Germany.

Mattias Collin (M)

Division of Infection Medicine, Department of Clinical Sciences, Lund University, Lund, Sweden.

Gabriela Salinas (G)

NGS-Integrative Genomics, Institute Human Genetics, University Medical Center Göttingen, Göttingen, Germany.

Rudolf A Manz (RA)

Institute for Systemic Inflammation Research, University of Lübeck, Lübeck, Germany.

Hidehiro Fukuyama (H)

Laboratory for Lymphocyte Differentiation, RIKEN Center for Integrative Medical Sciences, Yokohama, Kanagawa, Japan.

Thomas Korn (T)

Department of Neurology, Technical University of Munich, Klinikum rechts der Isar, Germany; Munich Cluster for Systems Neurology, SyNergy, Germany.

Ari Waisman (A)

Institute for Molecular Medicine, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.

Nir Yogev (N)

Clinic and Polyclinic for Dermatology and Venerology, University Hospital Cologne, Cologne, Germany.

Samuel Huber (S)

First Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Björn Rabe (B)

Institute of Biochemistry, Kiel University, Kiel, Germany.

Stefan Rose-John (S)

Institute of Biochemistry, Kiel University, Kiel, Germany.

Hauke Busch (H)

Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany.

Friederike Berberich-Siebelt (F)

Institute for Pathology, University of Würzburg, Würzburg, Germany; Comprehensive Cancer Center Mainfranken, University of Würzburg, Würzburg, Germany.

Christoph Hölscher (C)

Infection Immunology, Research Center Borstel, Borstel, Germany; German Center for Infection Research, Partner Site Hamburg-Lübeck-Borstel-Riems, Borstel, Germany.

Manfred Wuhrer (M)

Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.

Marc Ehlers (M)

Laboratories of Immunology and Antibody Glycan Analysis, Institute for Nutritional Medicine, University of Lübeck and University Medical Center Schleswig-Holstein, Lübeck, Germany; Laboratory of Tolerance and Autoimmunity at the German Rheumatism Research Center, a Leibniz Institute, Berlin, Germany; Airway Research Center North, University of Lübeck, German Center for Lung Research, Lübeck, Germany. Electronic address: marc.ehlers@uksh.de.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH